NCT07509190 · Anny Reyes
Bridging the Gap: Educating Patients on Social Determinants of Health to Improve Epilepsy Surgery Access and Outcomes
What this study is about
The goal of this study is to identify the needs and barriers to accessing and undergoing epilepsy surgery for patients with epilepsy and then to pilot an educational program regarding the social determinants of health and how they can influence surgical rates and epilepsy outcomes.
View original scientific description
The goal of this study is to identify the needs and barriers to accessing and undergoing epilepsy surgery for patients with epilepsy and then to pilot an educational program regarding the social determinants of health and how they can influence surgical rates and epilepsy outcomes. For the first part, patients (age 18+) and providers will be asked to complete surveys and participate in focus groups to identify gaps and barriers that limit access to and use of epilepsy surgery. For piloting the education program, patients (age 18+) at the Cleveland Clinic Epilepsy Monitoring Unit will be randomized to intervention or control. Those in the intervention group, in addition to their usual care, will also receive educational materials on social determinants of health and their influence on surgical rates and epilepsy outcomes. Those in the control group will receive their usual care. Both groups will be asked to fill out surveys and questionnaires at the beginning of their stay, at the end of their stay, and if they elect to have surgery, 12 months after surgery.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Epilepsy diagnosis
- Completion of epilepsy surgical evaluation at Cleveland Clinic
- Recommendation for resective/ablation surgery or implantation of neurostimulation device
- At least 18 years old
- Part 2a - Patient survey:
- At least 18 years old
- Epilepsy diagnosis
- Evaluated for epilepsy surgery
- English proficiency enough to complete survey
- Part 2a - Provider survey:
- Healthcare professional in the US who is involved in the clinical care or treatment of individuals with epilepsy
- Part 2b - Cleveland Clinic patient focus groups:
- Epilepsy diagnosis
- Previously completed epilepsy workup at Cleveland Clinic
- At least 18 years old
- Has Basic Interpersonal Fluency Skills in English (based on phone interview)
- Has no evidence of dementia or intellectual disability that would interfere with participation in the focus group
- Part 2b - Cleveland Clinic provider focus groups:
- Clinicians that are members of Cleveland Clinic Epilepsy Center and provide care to patients with epilepsy
- Part 2b - Community patient focus groups:
- Epilepsy diagnosis
- Previously completed epilepsy workup
- At least 18 years old
- Has Basic Interpersonal Fluency Skills in English (based on phone interview)
- Part 2b - Community provider focus groups:
- Clinician that provides care to patients with epilepsy outside of Cleveland Clinic
- At least 18 years old
- Fluent in English
- Being evaluated for epilepsy surgery at the Cleveland Clinic Epilepsy Monitoring Unit
Exclusion criteria
- Previous epilepsy surgery or implantation of neurostimulation device
- Part 2a - Patient survey:
- Unable to fluently read English
- Has evidence of dementia or intellectual disability that would interfere with patient's understanding of surveys
- Part 2a - Provider survey:
- Unable to fluently read English
- Part 2b - Cleveland Clinic patient focus groups:
- Is not fluent in English
- Has evidence of dementia or intellectual disability that would interfere with patient's understanding of or ability to participate in the focus group
- Has had prior epilepsy surgery
- Part 2b - Cleveland Clinic provider focus groups:
- Clinicians involved in the development of the study design
- Part 2b - Community patient focus groups:
- Is not fluent in English
- Has evidence of dementia or intellectual disability that would interfere with patient's understanding of or ability to participate in the focus group
- Has had prior epilepsy surgery
- Is not fluent in English
- Evidence of dementia or intellectual disability that would interfere with patient's understanding of intervention
Where
- Cleveland, Ohio
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Apr 3, 2026 · Source of record for eligibility and locations